Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum

Journal of Hepatology

Volumn 25, Issue 6, 1996, Pages 827-832

  Ampurdanés, Sergi ^a   Olmedo, Eva ^a   Maluenda, Maria D ^a   Forns, Xavier ^a   López Labrador, Francesc X ^a   Costa, Josep ^a   Sánchez Tapias, Jose M ^a,b   Jimenez De Anta, Maria T ^a   Rodés, Juan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Antiviral therapy; HCV; Hepatitis C virus; Viral hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS HEPATITIS;

EID: 0030473550     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80285-6     Document Type: Article

References (28)

1. 1. Davis GL. Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol 1994; 21: 1-3.
2. 2. Alberti A, Chemello L, Pontisso P, Noventa F, Casarin C, Bonetti P, Benvegnù L, Cavalletto L. Predictors of response to interferon in chronic hepatitis C. In: Dianzani F, Prieto Valtueña J, eds. Proceedings of the Second International Symposium on Lymphoblastoid alpha-interferon. London: Current Medical Literature Ltd., 1995: 27-32.
3. 3. Suzuki T, Tanaka E, Matsumoto A, Urushihara A, Sodeyama T. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis to interferon-2a therapy. J Med Virol 1995; 46: 162-8.
4. 4. Renault PF, Hoofnagle JH. Side effects of alpha interferon. Semin Liver Dis 1989; 9: 273-7.
5. 5. Janssen HLA, Brouwer JT, Nevens F, Sánchez-Tapias JM, Craxi A, Hadzyannis SJ. Fatal hepatic decompensation associated with interferon alpha. Br Med J 1993; 306: 107-8.
6. 6. Davis GL, Lau JY, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, Perrillo RP, Albretch J. Quantitative detection of hepatitis C virus (HCV) RNA by a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon treated patients. Hepatology 1994; 19: 1337-41.
7. 7. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673-9.
8. 8. Silini E, Bono F, Cerino A, Piazza V, Solfia E, Mondelli MU. Virological features of hepatitis C virus infection in hemodialysis patients. J Clin Microb 1993; 31: 2913-17.
9. 9. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS, Choo QL, Colombo M, Cuypers HTM, Date T, Dusheiko GM, Esteban JI, Fay O, Hadzyannis SJ, Han J, Hatzakis A, Holmes EC, Hotta H, Houghton M, Irwine B, Kohara M, Kolberg JA, Kuo G, Lau JYN, Lelie PN, Maertens G, McOmish F, Miyamura T, Mizokami M, Nomoto A, Prince AM, Reesink HW, Rice C, Roggendorf M, Schalm SW, Shikata T, Shimotohno K, Stuyver L, Trepo C, Weiner A, Yap PL, Urdea MS. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321-4 (Correspondence).
10. 10. Romeo R, Pol S, Berthelot P, Brechot C. Eradication of hepatitis C virus RNA after alpha-interferon therapy. Ann Intern Med 1994; 121: 276-7.
11. 11. Reichard O, Glaumann H, Fryden A, Norkrans G, Schvarcz R, Sönnerborg A, Yung ZB, Weiland O. Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment. Hepatology 1995; 21: 918-22.
12. 12. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata N, Morishima T. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alfa therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-9.
13. 13. Camps J, Crisostomo S, Garcia-Granero M, Riezu-Boj JI, Civeira MP, Prieto J. Prediction of the response of hepatitis C to interferon alfa: a statistical analysis of pretreatment variables. Gut 1993; 34: 1714-17.
14. 14. Serfaty L, Giral P, Loira A, Andréani T, Legendre C, Poupon R. Factors predictive of the response to interferon in patients with chronic hepatitis C. J Hepatol 1994; 21: 12-7.
15. 15. Mazzella G, Salzetta A, Casanova S, Morelli MC, Vilanova N, Miniero R. Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: gamma GT levels predictive for response. Dig Dis Sci 1994; 39: 866-70.
16. 16. Battezzati PM, Podda M, Bruno S, Zuin M, Crosignani A, Camisasca M, Chiesa A, Petroni ML, Russo A, Gallotti P, Borzio M, Borzio F, Buscarini L, Fornari F, Sbolli G, Lanzini A, Pigozzi MG, Salmi A, Dastoli G, Carriero PL. Factors predicting early response to treatment with recombinant interferon alpha-2a in chronic non-A, non-B hepatitis: preliminary report of a long-term trial. Ital J Gastroenterol 1992; 24: 481-4.
17. 17. Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, Kamada T. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 1993; 104: 877-83.
18. 18. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Hiromitsu K. Factors predictive of response to interferon-alfa therapy in hepatitis C virus infection. Hepatology 1994; 19: 1088-94.
19. 19. Camps J, García-Granero M, Riezu-Boj JI, Larrea E, de Alava E, Civeira MP, Castilla J. Prediction of sustained remission of chronic hepatitis C after a 12 month course of alfa interferon. J Hepatol 1994; 21: 4-11.
20. 20. Shindo M, Arai K, Sokawa Y, Okuno T. Hepatic C virus RNA as a predictor of a long-term response to interferon-therapy. Ann Intern Med 1995; 122: 586-91.
21. 21. Saracco G, Rosina F, Abate ML, Chiandussi L, Gallo V, Cerutti E, Di Napoli A, Solinas A, Deplano A, Tocco A, Cossu P, Chien D, Kuo G, Polito A, Weiner AJ, Houghton M, Verme G, Bonino F, Rizetto M. Long-term follow-up of patients with chronic hepatitis C treated with different doses on interferon-2b. Hepatology 1993; 18: 300-5.
22. 22. Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722-4.
23. 23. Young K, Resnick RM, Myers TW. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Med Microb 1993; 31: 882-6.
24. 24. Nolte FS, Thurmond C, Fried MW. Preclinical evaluation of Amplicor hepatitis C virus test for detection of hepatitis C virus RNA. J Med Microbiol 1995; 33: 1775-8.
25. 25. Davis GL, Ballart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, VanThiel D, Tamburro C, Lefkowitch J, Albretch J, Meschievitz C, Ortego TJ, Gibas A, and the Hepatitis Interventional Group. Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized controlled trial. N Engl J Med 1989; 321: 1501-6.
26. 26. Kleter GE, Brouwer GT, Heijtink RA, Schalm SW, Quint WG. Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha-interferon. Antimicrob Agents Chemoterap 1993; 37: 595-7.
27. 27. Pol S, Jaffredo F, Nalpas B, Sayada C, Berthelot P, Brechot C. Predictive value of HCV viremia after 3 months in the monitoring of antiviral treatments. Hepatology 1994; 20: 159A (Abstract).
28. 28. Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mori M, Hayashi K, Kato K, Iino S, Lau JYN. Loss of serum HCV-RNA at week four of interferon-therapy is associated with more favorable long-term response in patients with chronic hepatitis C. J Med Virol 1995; 46: 109-15.